AbbVie

News

Chronic lymphocytic leukemia (CLL) is a type of cancer of the blood and bone marrow - the spongy tissue inside bones where blood cells are made.

Roche/AbbVie combination could raise standards in CLL

A leukaemia combination therapy could help revive the fortunes of Roche and AbbVie, following late-stage trial results showing it significantly reduces risk of progression in CLL compared w

News

AbbVie to file long-acting psoriasis contender

AbbVie hopes risankizumab will rebuild sales after Humira patent expires

Partner Content

Partner Content

Abbvie and Astrazeneca to present keynote address’ at SMi’s ...

Drug Discovery conference 2018

News

Boehringer's Humira biosimilar approved in EU

AbbVie’s big-selling Humira will face competition from at least three biosimilars in Europe in around a year’s time, after the European Commission approved a biosimilar from Boehringer Inge

News